cardiovascular system
• left ventricular mass is increased as compared to controls by 9 weeks of age
|
• decreased ejection fraction as compared to controls by 7 weeks of age
• decreased fractional shortening as compared to controls by 7 weeks of age
|
• decreased heart rate by 7 weeks of age
|
• progressive cardiomyopathy
|
mortality/aging
• mean survival is 86 +/- days of age
|
muscle
• decreased ejection fraction as compared to controls by 7 weeks of age
• decreased fractional shortening as compared to controls by 7 weeks of age
|
• progressive cardiomyopathy
|